Target intelligence / Profile preview

Salmonella Enteritidis lipopolysaccharide O-antigen (LPS O-antigen (sometimes abbreviated as O-Ag); no unique, widely accepted abbreviation specific to Salmonella Enteritidis found)

Target
LPS O-antigen (sometimes abbreviated as O-Ag); no unique, widely accepted abbreviation specific to Salmonella Enteritidis found
Molecular classification
Other (polysaccharide antigen), Surface antigen, Bacterial outer membrane component
01

Overview

The Salmonella Enteritidis lipopolysaccharide O-antigen is the highly variable, distal polysaccharide segment of the LPS molecule found on the outer membrane of Salmonella Enteritidis. It consists of repeating oligosaccharide units (typically four sugars in Salmonella Enteritidis: rhamnose, mannose, galactose, and tyvelose), which confer strain-specific antigenicity and allow differentiation between serovars. The O-antigen protects the bacterium from host immune defenses, particularly the complement system, and supports virulence by enabling bacterial survival, colonization, airbags resistance to environmental stresses. Its variable structure underlies most of the antigenic diversity among Salmonella strains, making it a critical target for diagnostics, serotyping, and the development of vaccines and immunotherapies. Structural and compositional variation in the O-antigen is a major therapeutic and research challenge, as it impacts both host-pathogen interactions and the design of broad-spectrum interventions.

Other names
O-antigenO-polysaccharideO-specific polysaccharide (O-Ag)LPS O-antigenSalmonella Enteritidis O-antigen
02

Mechanism of action

Antibody-mediated neutralization and opsonization (for vaccines and immunotherapies); Potential phage attachment (some bacteriophages recognize O-antigen as binding targets); Inhibition of biosynthetic enzymes (preclinical models for antibiotics disrupting LPS assembly)

03

Biological functions

Immune evasion (protection from complement-mediated lysis and opsonophagocytosis)Virulence factor (facilitates bacterial survival and colonization in the host)Serotype determinant (basis of O-serotyping between Salmonella strains)Barrier function (helps resist antibiotics and detergents)
04

Disease associations

Infection (crucial for systemic Salmonella Enteritidis infection and survival in host)Other (inflammatory response inducer due to LPS)
05

Safety considerations

Endotoxemia and septic shock risk if LPS is released during infection or treatment (because lipid A domain induces strong inflammatory response)Antigenic diversity limits universal vaccine design (O-antigen structure varies between strains)Possibility of immune escape due to high O-antigen variability
06

Interacting drugs

Monoclonal antibodies (under investigation)

2 more in the full profile.

07

Biomarkers

O-antigen-specific antibodies (used for serological typing and diagnostics)O-antigen length and sugar composition (help differentiate Salmonella Enteritidis from other serovars)

Beyond the preview

Go deeper on Salmonella Enteritidis lipopolysaccharide O-antigen (LPS O-antigen (sometimes abbreviated as O-Ag); no unique, widely accepted abbreviation specific to Salmonella Enteritidis found).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Enteritidis lipopolysaccharide O-antigen (LPS O-antigen (sometimes abbreviated as O-Ag); no unique, widely accepted abbreviation specific to Salmonella Enteritidis found).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call